Angina Pectoris Market Segmentation Detailed Study with Forecast to 2012 - 2018

Angina pectoris market is expected to grow at the CAGR of 3.5% and reach the value of $12,707.4 million by the year 2018. This growth is primarily driven by the increase in number of patients undergoing treatment for angina pectoris and likely approval of new therapies like varespladib and Generx that are in late stage of clinical development. If approved, these products are expected to contribute in the growth of angina pectoris industry as they will be marketed at premium price by their inventor companies. Innovative mechanism of action of these products will lead to improvements in effectiveness and safety over currently marketed products. 

Current treatments available of angina pectoris are not that effective and hence there are increasing opportunities for new market players to develop more effective therapies and contribute to the market growth. Currently, there is less competition in this industry, thus creating new growth opportunities for emerging players in this field. The continuous research and developments in this field is spurring the growth of this industry and the future seems bright with introduction of novel and effective drugs.

Get Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=630

This research report analyzes this market based in its market segments and major geographies. Geographies analyzed under this research report include North America, Asia Pacific, Europe, and Rest of the World. This research report provides comprehensive analysis of current industry trends, factors driving market growth, restraints, industry structure, and market projections for upcoming years. Report also includes analysis of technological developments in this market, Porter’s five force model analysis, and complete company profiles of top industry players. It provides review of micro and macro factors significant with respect to existing market players and new entrants along with detailed value chain analysis. 

Get Discount on Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=630

Some of the major players dominating this market are Anthera Pharmaceuticals, Cardium Therapeutics, Astellas Pharma, Sanofi, Bayer HealthCare, Cardeus Pharmaceuticals and CardioVascular BioTherapeutics (CVBT), Merck & Co. Inc., Ark Therapeutics Group plc, Torrent Pharmaceuticals Limited, Circ Pharma Limited, HUYA Bioscience International LLC, Lacer S.A., Viromed Co. Ltd., Baxter Healthcare Corporation, and others. 

Report Details @ https://www.transparencymarketresearch.com/angina-pectoris-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.